Full name
BIOMERIEUX POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
33.13.Z - Repair and maintenance of electronic and optical equipment
33.14.Z - Repair and maintenance of electrical equipment
49.41.Z - Freight transport by road
52.10.B - Warehousing and storage of other goods
64.91.Z - Financial leasing
68.20.Z - Rental and operating of own or leased real estate
70.22.Z - Business and other management consultancy activities
71.20.B - Other technical testing and analysis
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 6,7 | 8,5 | 4,5 | -47,3 |
EBITDA | 13,3 | 16,5 | 13,8 | -16,3 |
Short time liabilities | 32,5 | 33,3 | 38,3 | 14,9 |
Equity capital | 34,4 | 39,9 | 38,4 | -3,7 |
Operating profit (EBIT) | 6,8 | 8,6 | 4,6 | -46,3 |
Assets | 72,4 | 79,9 | 85,5 | 7 |
Net profit (loss) | 5,2 | 7,3 | 3,2 | -56 |
Cash | 0,2 | 0,8 | 0,2 | -71,9 |
Net income from sale | 123,8 | 131,1 | 158,3 | 20,7 |
Liabilities and provisions for liabilities | 38 | 40 | 47 | 17,6 |
Working assets | 36,8 | 36,9 | 36,9 | -0,2 |
Depreciation | 6,5 | 7,9 | 9,2 | 16,2 |
% | % | % | p.p. | |
Profitability of capital | 15,1 | 18,4 | 8,4 | -10 |
Equity capital to total assets | 47,5 | 49,9 | 44,9 | -5 |
Gross profit margin | 5,4 | 6,5 | 2,8 | -3,7 |
EBITDA Margin | 10,7 | 12,6 | 8,7 | -3,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 96 | 93 | 88 | -5 |
Current financial liquidity indicator | 1.0758079290390015 | 1.0340462923049927 | 0.8876268267631531 | -0,1 |
Net dept to EBITDA | 0.09527906775474548 | 0.037846148014068604 | 0.12332703173160553 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane